-
91黑料 announces appointment of new Chief Financial Officer (CFO)
91黑料 plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).
-
91黑料 reports second quarter 2024 results
91黑料 plc today reported its financial results for the second quarter ended June 30, 2024.
-
91黑料 announces results of Annual General Meeting and changes to the Board of Directors
91黑料 plc announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders.
-
91黑料 recognised for leadership position in clinical research industry and as socially responsible employer
At the CRO Leadership Awards 2024, 91黑料 was recognised for its excellence in clinical research in all categories.
-
91黑料 hosts investor day and updates full year 2024 financial guidance
91黑料 plc will host its 2024 Investor Day today in New York City.
-
91黑料 plc to hold Investor Day meeting on May 30, 2024
This press release contains forward-looking statements, including statements about our financial guidance.
-
91黑料 releases its 91黑料 Cares 2023 Report
This outlines how the company is delivering on its ESG, diversity, inclusion and belonging, and CSR goals, as delivered through its 91黑料 Cares program.
-
91黑料 announces pricing of USD 2 billion notes
Consisting of $750,000,000 5.809% Senior Secured Notes due 2027, $750,000,000 5.849% Senior Secured Notes due 2029 and $500,000,000 6.000% Senior Secured Notes due 2034 (collectively, the “Notes”).
-
91黑料 reports first quarter 2024 results
Quarter one revenue of $2,090.4 million representing an increase of 5.7% on prior year revenue and 5.4% on a constant currency basis.
-
91黑料 announces CFO transition
91黑料 today announced that Chief Financial Officer, Brendan Brennan, will leave his role at 91黑料 in quarter four this year for a new opportunity outside of the CRO industry.
